223 related articles for article (PubMed ID: 16939397)
21. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
22. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
[TBL] [Abstract][Full Text] [Related]
23. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
Aitken CJ; Hodge JM; Nishinaka Y; Vaughan T; Yodoi J; Day CJ; Morrison NA; Nicholson GC
J Bone Miner Res; 2004 Dec; 19(12):2057-64. PubMed ID: 15537450
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
25. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
26. Expression of RHOGTPase regulators in human myometrium.
O'Brien M; Flynn D; Mullins B; Morrison JJ; Smith TJ
Reprod Biol Endocrinol; 2008 Jan; 6():1. PubMed ID: 18190708
[TBL] [Abstract][Full Text] [Related]
27. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
29. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
30. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ
J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840
[TBL] [Abstract][Full Text] [Related]
31. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
[TBL] [Abstract][Full Text] [Related]
32. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
[TBL] [Abstract][Full Text] [Related]
33. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis.
Beranger GE; Momier D; Rochet N; Quincey D; Guigonis JM; Samson M; Carle GF; Scimeca JC
J Bone Miner Res; 2006 Nov; 21(11):1757-69. PubMed ID: 17002555
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone.
Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z
Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214
[TBL] [Abstract][Full Text] [Related]
35. Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank.
Kapur RP; Yao Z; Iida MH; Clarke CM; Doggett B; Xing L; Boyce BF
J Bone Miner Res; 2004 Oct; 19(10):1689-97. PubMed ID: 15355564
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of RANKL implicates IFN-beta-mediated elimination of B-cell precursors in the osteopetrotic bone of microphthalmic mice.
Roundy K; Smith R; Weis JJ; Weis JH
J Bone Miner Res; 2003 Feb; 18(2):278-88. PubMed ID: 12568405
[TBL] [Abstract][Full Text] [Related]
37. Identification of genes differentially expressed in osteoclast-like cells.
Nomiyama H; Egami K; Wada N; Tou K; Horiuchi M; Matsusaki H; Miura R; Yoshie O; Kukita T
J Interferon Cytokine Res; 2005 Apr; 25(4):227-31. PubMed ID: 15812249
[TBL] [Abstract][Full Text] [Related]
38. Rho GTPase techniques in osteoclastogenesis.
Leung R; Glogauer M
Methods Mol Biol; 2012; 827():167-79. PubMed ID: 22144275
[TBL] [Abstract][Full Text] [Related]
39. RhoV mediates apoptosis of RAW264.7 macrophages caused by osteoclast differentiation.
Song R; Liu X; Zhu J; Gao Q; Wang Q; Zhang J; Wang D; Cheng L; Hu D; Yuan Y; Gu J; Liu Z
Mol Med Rep; 2015 Feb; 11(2):1153-9. PubMed ID: 25354898
[TBL] [Abstract][Full Text] [Related]
40. Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.
Baud'huin M; Ruiz-Velasco C; Jego G; Charrier C; Gasiunas N; Gallagher J; Maillasson M; Naggi A; Padrines M; Redini F; Duplomb L; Heymann D
Eur J Cell Biol; 2011 Jan; 90(1):49-57. PubMed ID: 20970218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
